| Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$152 |
Investor Briefing Invitation
|
16 Jul 2025 10:13AM |
$0.029 |
$0.165 |
risen by
468.97%
|
|
| Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$152 |
Reinstatement to Quotation
|
16 Jul 2025 10:11AM |
$0.029 |
$0.165 |
risen by
468.97%
|
|
LDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Lumos Diagnostics Holdings Limited (ASX: LDX) will be reinstated to official quotation on the ASX.
- Reinstatement follows the company meeting ASX Listing Rule requirements.
- Details provided on capital raisings and changes to the board structure.
- Background given on the previous suspension of LDX shares.
- Steps outlined that LDX took to address issues leading to suspension.
- Reinstatement process and implications for shareholders are explained.
- Company has improved its financial position and governance structure.
- ASX confirms all necessary documentation and compliance are satisfied.
- Trading in LDX securities will recommence on 13 June 2024.
- Shareholders are advised of the process and next steps following reinstatement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$152 |
Lumos Signs Pivotal US FebriDx Agreement
|
16 Jul 2025 10:11AM |
$0.029 |
$0.165 |
risen by
468.97%
|
|
LDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Lumos Diagnostics Holdings Limited has signed a pivotal US clinical trial agreement for FebriDx.
- The agreement is aimed at obtaining FDA clearance for FebriDx in the United States.
- FebriDx is a point-of-care diagnostic test that distinguishes between bacterial and viral infections.
- The agreement marks a significant step in Lumos Diagnostics’ US market strategy.
- The clinical trial is essential for the commercial launch of FebriDx in the US healthcare sector.
- The document discusses the clinical, regulatory, and commercial significance of the agreement.
- Details include projected timelines and the scope of the pivotal clinical study for FDA approval.
- The agreement may positively impact Lumos Diagnostics’ competitive position and financial prospects.
- Risks and contingencies related to FDA approval and market adoption are addressed.
- The agreement is a major advancement towards expanding Lumos Diagnostics' presence in the US diagnostics market.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Zeus Resources Limited (ZEU) ORDINARY FULLY PAID |
Energy |
$6 |
Zeus Appoints US Business Development & Strategy Advisor
|
16 Jul 2025 10:08AM |
$0.017 |
$0.009 |
fallen by
47.06%
|
|
| Clean TeQ Water Limited (CNQ) ORDINARY FULLY PAID |
Industrials |
$35 |
Initial Director's Interest Notice - D Pfeffer
|
16 Jul 2025 10:05AM |
$0.210 |
$0.400 |
risen by
90.48%
|
|
| Monash IVF Group Limited (MVF) ORDINARY FULLY PAID |
Health Care |
$284 |
Appointment of Interim Chief Financial Officer
|
16 Jul 2025 10:04AM |
$0.730 |
$0.730 |
fallen by
0%
|
|
| Anson Resources Limited (ASN) ORDINARY FULLY PAID |
Materials |
$97 |
Anson Successfully Polishes Green River Lithium Chloride
|
16 Jul 2025 10:03AM |
$0.092 |
$0.060 |
fallen by
34.78%
|
|
ASN - Price-sensitive ASX Announcement
Full Release
Key Points
- Anson Resources successfully produced high-purity lithium chloride from Green River brine.
- The lithium chloride concentrate meets battery-grade requirements after proprietary polishing.
- The project is located in Utah, USA, targeting the US battery and EV markets.
- Production is an important step toward commercial battery-grade lithium output.
- The high-purity lithium chloride will be further processed into lithium carbonate and hydroxide.
- Ongoing project activities include permitting, site works, and preparing for commercial operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clean Seas Seafood Limited (CSS) ORDINARY FULLY PAID |
Consumer Staple |
- |
Court Approves Scheme of Arrangement
|
16 Jul 2025 10:02AM |
$0.135 |
$0.135 |
fallen by
0%
|
|
| Clean TeQ Water Limited (CNQ) ORDINARY FULLY PAID |
Industrials |
$35 |
Appointment of New Director
|
16 Jul 2025 10:01AM |
$0.210 |
$0.400 |
risen by
90.48%
|
|
| Lord Resources Limited (LRD) ORDINARY FULLY PAID |
Materials |
$3 |
Notification regarding unquoted securities - LRD
|
16 Jul 2025 10:01AM |
$0.023 |
$0.019 |
fallen by
17.39%
|
|
| Caspin Resources Limited (CPN) ORDINARY FULLY PAID |
Materials |
$34 |
Completion of Tranche 2 Placement and Cleansing Statement
|
16 Jul 2025 10:00AM |
$0.051 |
$0.115 |
risen by
125.49%
|
|
| Caspin Resources Limited (CPN) ORDINARY FULLY PAID |
Materials |
$34 |
Notification regarding unquoted securities - CPN
|
16 Jul 2025 10:00AM |
$0.051 |
$0.115 |
risen by
125.49%
|
|
| Scalare Partners Holdings Limited (SCP) ORDINARY FULLY PAID |
Consumer Staple |
$6 |
Appointment of Joint Company Secretary
|
16 Jul 2025 9:59AM |
$0.170 |
$0.070 |
fallen by
58.82%
|
|
| Terra Critical Minerals Limited (T92) ORDINARY FULLY PAID |
Energy |
$11 |
Terra Uranium Appoints Experienced Technical Advisors
|
16 Jul 2025 9:55AM |
$0.037 |
$0.077 |
risen by
108.11%
|
|
| Arena REIT (ARF) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,410 |
Update - Dividend/Distribution - ARF
|
16 Jul 2025 9:55AM |
$3.640 |
$3.480 |
fallen by
4.40%
|
|
| Lord Resources Limited (LRD) ORDINARY FULLY PAID |
Materials |
$3 |
Application for quotation of securities - LRD
|
16 Jul 2025 9:54AM |
$0.023 |
$0.019 |
fallen by
17.39%
|
|
| Hawsons Iron Ltd (HIO) ORDINARY FULLY PAID |
Materials |
$20 |
Share Purchase Plan Results and Placement
|
16 Jul 2025 9:54AM |
$0.022 |
$0.016 |
fallen by
27.27%
|
|
HIO - Price-sensitive ASX Announcement
Full Release
Key Points
- Successful completion of Share Purchase Plan (SPP) with applications exceeding targets.
- Board approved accepting oversubscriptions to accommodate shareholder demand.
- Proceeds to support advancement of the Hawsons Iron Project, including pre-feasibility activities and working capital.
- Clear timeline provided for the issue and allocation of new shares to participants.
- Placement conducted alongside SPP to further strengthen the company’s financial position.
- Company acknowledges and thanks shareholders for their ongoing support.
- The announcement emphasizes continued focus on progressing key project development milestones.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Warriedar Resources Limited (WA8) ORDINARY FULLY PAID |
Materials |
- |
Quarterly Activities/Appendix 5B Cash Flow Report
|
16 Jul 2025 9:53AM |
$0.110 |
$0.265 |
risen by
140.91%
|
|
WA8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report covers activities up to 31 March 2024.
- Exploration and drilling focused at Golden Range and Fields Find in Western Australia.
- Maiden Mineral Resource Estimate (MRE) announced for Ricciardo deposit.
- Additional positive drilling results reported, indicating further project potential.
- Successful capital raising of $6.2 million and completion of a share purchase plan.
- Strengthened company board and management with new appointments.
- Operational and financial highlights discussed, including cash flow statements.
- Commitment to environmental and community engagement initiatives.
- Outlined near-term exploration activities and strategic objectives for the following quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Caspin Resources Limited (CPN) ORDINARY FULLY PAID |
Materials |
$34 |
Application for quotation of securities - CPN
|
16 Jul 2025 9:52AM |
$0.051 |
$0.115 |
risen by
125.49%
|
|
| American Rare Earths Limited (ARR) ORDINARY FULLY PAID |
Materials |
$207 |
Updated Announcement -Metallurgical Test Holes
|
16 Jul 2025 9:51AM |
$0.345 |
$0.360 |
risen by
4.35%
|
|
ARR - Price-sensitive ASX Announcement
Full Release
Key Points
- Updated announcement on metallurgical test holes at Halleck Creek Rare Earths Project.
- Drilling program conducted to collect samples for metallurgical testing.
- Results confirm successful mineral recovery rates and increased knowledge of the ore body.
- Test work supports ongoing feasibility studies for rare earths extraction.
- Focus on optimizing metallurgical processes for improved extraction efficiency.
- Commitment to further metallurgical assessments to enhance project viability.
- Next steps include additional drilling and resource development activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Midas Minerals Ltd (MM1) ORDINARY FULLY PAID |
Materials |
$215 |
Issue of Shares and Cleansing Notice
|
16 Jul 2025 9:48AM |
$0.295 |
$0.890 |
risen by
201.69%
|
|
| Midas Minerals Ltd (MM1) ORDINARY FULLY PAID |
Materials |
$215 |
Change of Director's Interest Notice x 3
|
16 Jul 2025 9:47AM |
$0.295 |
$0.890 |
risen by
201.69%
|
|
| Newmont Corporation (NEM) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$12,768 |
Update on Monetization of Equity Stake
|
16 Jul 2025 9:47AM |
$93.030 |
$155.590 |
risen by
67.25%
|
|
| Spenda Limited (SPX) ORDINARY FULLY PAID |
Information Technology |
$12 |
Investor Presentation
|
16 Jul 2025 9:47AM |
$0.007 |
$0.002 |
fallen by
71.43%
|
|
| Future Generation Global Limited (FGG) ORDINARY FULLY PAID |
Financials |
$662 |
Investment portfolio outperformance, increased ff dividend
|
16 Jul 2025 9:46AM |
$1.515 |
$1.650 |
risen by
8.91%
|
|
FGG - Price-sensitive ASX Announcement
Full Release
Key Points
- FGG's investment portfolio outperformed its benchmark during the 2022-2023 financial year.
- The company announced an increased fully franked dividend, benefiting shareholders.
- Part of the profits are directed towards youth mental health initiatives, maintaining FGG's social impact mission.
- Strong investment returns were achieved through active management and diversification in global equities.
- FGG remains committed to both delivering investment returns and making positive philanthropic contributions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.